216 related articles for article (PubMed ID: 38169295)
1. An
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JL; O'Toole GA
J Bacteriol; 2024 Jan; 206(1):e0028623. PubMed ID: 38169295
[TBL] [Abstract][Full Text] [Related]
2. An In Vitro Medium for Modeling Gut Dysbiosis Associated with Cystic Fibrosis.
Barrack KE; Hampton TH; Valls RA; Surve SV; Gardner TB; Sanville JL; Madan JC; O'Toole GA
bioRxiv; 2023 Aug; ():. PubMed ID: 37577487
[TBL] [Abstract][Full Text] [Related]
3. Development of the intestinal microbiome in cystic fibrosis in early life.
Price CE; Hampton TH; Valls RA; Barrack KE; O'Toole GA; Madan JC; Coker MO
mSphere; 2023 Aug; 8(4):e0004623. PubMed ID: 37404016
[TBL] [Abstract][Full Text] [Related]
4. Intestinal
Price CE; Valls RA; Ramsey AR; Loeven NA; Jones JT; Barrack KE; Schwartzman JD; Royce DB; Cramer RA; Madan JC; Ross BD; Bliska J; O'Toole GA
mBio; 2024 Feb; 15(2):e0314423. PubMed ID: 38179971
[TBL] [Abstract][Full Text] [Related]
5. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
7. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
8. The Gut-Lung Axis in Cystic Fibrosis.
Price CE; O'Toole GA
J Bacteriol; 2021 Sep; 203(20):e0031121. PubMed ID: 34339302
[TBL] [Abstract][Full Text] [Related]
9. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
[TBL] [Abstract][Full Text] [Related]
10. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
Garg M; Ooi CY
Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
[TBL] [Abstract][Full Text] [Related]
11. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
[TBL] [Abstract][Full Text] [Related]
12. Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh R; Dos Santos C; Hanson L; Ng C; Major G; Smyth AR; Rivett D; van der Gast C
Microbiol Spectr; 2023 Aug; 11(5):e0117523. PubMed ID: 37607068
[TBL] [Abstract][Full Text] [Related]
13. Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.
Madan JC
Clin Ther; 2016 Apr; 38(4):740-6. PubMed ID: 26973296
[TBL] [Abstract][Full Text] [Related]
14. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures.
Madan JC; Koestler DC; Stanton BA; Davidson L; Moulton LA; Housman ML; Moore JH; Guill MF; Morrison HG; Sogin ML; Hampton TH; Karagas MR; Palumbo PE; Foster JA; Hibberd PL; O'Toole GA
mBio; 2012; 3(4):. PubMed ID: 22911969
[TBL] [Abstract][Full Text] [Related]
15. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis.
Marsh R; Gavillet H; Hanson L; Ng C; Mitchell-Whyte M; Major G; Smyth AR; Rivett D; van der Gast C
J Cyst Fibros; 2022 May; 21(3):506-513. PubMed ID: 34895838
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut.
Wang Y; Leong LEX; Keating RL; Kanno T; Abell GCJ; Mobegi FM; Choo JM; Wesselingh SL; Mason AJ; Burr LD; Rogers GB
Gut Microbes; 2019; 10(3):367-381. PubMed ID: 30359203
[TBL] [Abstract][Full Text] [Related]
17. The Microbiome in Cystic Fibrosis Pulmonary Disease.
Françoise A; Héry-Arnaud G
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403302
[TBL] [Abstract][Full Text] [Related]
18. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
[TBL] [Abstract][Full Text] [Related]
19. Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.
Antosca KM; Chernikova DA; Price CE; Ruoff KL; Li K; Guill MF; Sontag NR; Morrison HG; Hao S; Drumm ML; MacKenzie TA; Dorman DB; Feenan LM; Williams MA; Dessaint J; Yuan IH; Aldrich BJ; Moulton LA; Ting L; Martinez-Del Campo A; Stewart EJ; Karagas MR; O'Toole GA; Madan JC
J Bacteriol; 2019 Aug; 201(16):. PubMed ID: 31209076
[TBL] [Abstract][Full Text] [Related]
20. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]